Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on Apr 05, 2023 5:44pm
93 Views
Post# 35382004

UK medical cannabis patient numbers could surge in 2023

UK medical cannabis patient numbers could surge in 2023

''analysts predict that patient numbers will hit over 47,000 by the end of the year.

While there is no official data on the exact number of patients currently prescribed cannabis in the UK, experts believe the figure to be around 25,000-30,000, with more than 20 clinics prescribing the treatment privately. ''

'' analysts calculate that the annual number of products prescribed during 2022 amounts to around 76,600, a 90% increase from the year before.'' 


''The report, which examines the outlook of the European medical cannabis industry, says demand continues to rise across the continent with sales projected to reach over €550 million by the end of 2023.''

https://cannabishealthnews.co.uk/2023/03/30/uk-medical-cannabis-patient-numbers-surge-in-2023/

<< Previous
Bullboard Posts
Next >>